2009•Di-Si Junyi Daxue xuebaoRequires access

Protective immunity of recombinant EgP-29 against Echinococcus Granulosus in mice

Zhi Shi

Open publisher page 0 citations

Abstract

AIM:To investigate the protective immunity against Echinococcus granulosus in mice immunized with rEgP-29 and its potential as vaccine candidate.METHODS:ICR mice were subcutaneously immunized three times with rEgP-29 and then challenged with Echinococcus granulosus.The rate of reduced hydatid cyst and the levels of IgE,IgG and IgG subclasses in sera were examined,with adjuvant group as control.RESULTS:The rate of reduced hydatid cyst in rEgP-29 group was 96.6%.The levels of IgG,IgG1,IgG2a and IgE increased obviously,that of IgG2b decreased remarkably.CONCLUSION:The rEgP-29 antigen could induce partial protection against Echinococcus granulosus.These data demonstrate the potential of rEgP-29 as a Echinococcus granulosus vaccine candidate.

About this research paper

What this paper is about

AIM:To investigate the protective immunity against Echinococcus granulosus in mice immunized with rEgP-29 and its potential as vaccine candidate.METHODS:ICR mice were subcutaneously immunized three times with rEgP-29 and then challenged with Echinococcus granulosus.The rate of reduced hydatid cyst and the levels of IgE,IgG and IgG subclasses in sera were examined,with adjuvant group as control.RESULTS:The rate of reduced hydatid cyst in rEgP-29 group was 96.6%.The levels of IgG,IgG1,IgG2a and IgE increased obviously,that of IgG2b decreased remarkably.CONCLUSION:The rEgP-29 antigen could induce partial protection against Echinococcus granulosus.These data demonstrate the potential of rEgP-29 as a Echinococcus granulosus vaccine candidate.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To investigate the protective immunity against Echinococcus granulosus in mice immunized with rEgP-29 and its potential as vaccine candidate.METHODS:ICR mice were subcutaneously immunized three times with rEgP-29 and then challenged with Echinococcus granulosus.The rate of reduced hydatid cyst and the levels of IgE,IgG and IgG subclasses in sera were examined,with adjuvant group as control.RESULTS:The rate of reduced hydatid cyst in rEgP-29 group was 96.6%.The levels of IgG,IgG1,IgG2a and IgE increased obviously,that of IgG2b decreased remarkably.CONCLUSION:The rEgP-29 antigen could induce partial protection against Echinococcus granulosus.These data demonstrate the potential of rEgP-29 as a Echinococcus granulosus vaccine candidate.

Key concepts: Echinococcus granulosus, Echinococcus, Adjuvant, Immunology, Immunity, Echinococcosis, Immunoglobulin E, Antigen

Related papers

Back to paper searchBrowse research topicsOriginal source
Protective immunity of recombinant EgP-29 against Echinococcus Granulosus in mice — Research Paper | ScholarLens